Beatriz Colom-Fernández

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Anna Kreutzman, Beatriz Colom-Fernández, Ana Marcos‐Jiménez et al. · Clinical Cancer Research · 2017 · 43 citations

Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring

Aneta Wojnicz, Beatriz Colom-Fernández, Juan Luis Steegmann et al. · Therapeutic Drug Monitoring · 2017 · 20 citations

Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia

Carlos Cuesta‐Mateos, Javier Loscertales, Anna Kreutzman et al. · Cancer Immunology Immunotherapy · 2015 · 18 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +13

A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD

Itxaso Portero-Sáinz, Valle Gómez-Garcı́a de Soria, Carlos Cuesta‐Mateos et al. · Bone Marrow Transplantation · 2017 · 17 citations · Full text

Transplantation, Autoimmune Disease, Medicine +10

Autoantibodies against <scp>TIF</scp>‐1‐γ and <scp>CADM</scp>‐140 in Spanish patients with clinically amyopathic dermatomyositis (<scp>CADM</scp>): clinical significance and diagnostic utility

Carlos Cuesta‐Mateos, Beatriz Colom-Fernández, Itxaso Portero-Sáinz et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 15 citations